Humira biosimilars available at up to 80 percent discount in Europe: AbbVie
November 2, 2018
Exxon Mobil profit tops estimates but production falls
November 2, 2018

AbbVie lifts profit target after cancer drug powers quarterly beat

AbbVie Inc beat Wall Street estimates for third-quarter profit on Friday, driven by strong sales of blockbuster cancer medicine Imbruvica, and the drugmaker raised its 2018 earnings forecast, sending its shares up 4 percent.

Powered by WPeMatico